DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/bt2f5l/diabetic) has announced the addition of the "Diabetic Retinopathy Global Clinical Trials Review, H1, 2014" report to their offering.
Diabetic Retinopathy Global Clinical Trials Review, H1, 2014 provides data on the Diabetic Retinopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Retinopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.
The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diabetic Retinopathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Espy the commercial landscape of the major Universities / Institutes / Hospitals & Companies
- Novartis AG
- Pfizer Inc.
- Valeant Pharmaceuticals International, Inc.
- Allergan, Inc.
- Takeda Pharmaceutical Company Limited
- Eli Lilly and Company
- AstraZeneca PLC
- BCN Peptides, S.A.
- National Eye Institute
- University of Sao Paulo
- National Taiwan University Hospital
- Association for Innovation and Biomedical Research on Light and Image
- Medical University of Vienna
- Moorfields Eye Hospital NHS Foundation Trust
- Diabetic Retinopathy Clinical Research Network
- Shahid Beheshti University of Medical Sciences
- HOSPITAL JUAREZ DE MEXICO
- Federal University of Sao Paulo
For more information visit http://www.researchandmarkets.com/research/bt2f5l/diabetic
